ARE YOU AGED BETWEEN 50 and 80 YEARS OLD? ARE YOU FULLY VACCINATED AGAINST COVID-19 (with or without a booster)? You may qualify* to take part in a trial for …
CONDITION: Other
GENDER: Both males and females
AGE GROUP: 50 to 80 years
TRIAL STATUS: Completed
Patients presenting to the emergency department with an acute ischemic stroke due to a large vessel occlusion eligible for thrombectomy and target mismatch on computed tomography perfusion imaging within 24 …
CONDITION: Stroke
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Completed
One stick of sugar-free peppermint-flavoured chewing gum (Wrigley’s Extra Sugarfree Gum, Wrigley Company) in the event of nausea, retching and/or vomiting occurring in the post anaesthesia care unit (PACU) after …
CONDITION: Anaesthesiology
GENDER: Females
AGE GROUP: 12 and above
TRIAL STATUS: Completed
VAPOR-C is a randomised study of the impact of IV versus inhaled anaesthesia (propofol versus sevoflurane) and lidocaine versus no lidocaine on duration of disease free survival inpatients with either …
CONDITION: Anaesthesiology
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
About this clinical trial: Wesley Medical Research is seeking research participants for a study evaluating the safety and tolerability of an investigational drug for Amyotrophic lateral sclerosis (ALS) and how …
CONDITION: Neurological
GENDER: Both males and females
AGE GROUP: 18 to 75 years
TRIAL STATUS: Recruiting
Australian researchers are testing a new treatment for non-alcoholic steatohepatitis (NASH), an advanced form of non-alcoholic fatty liver disease (NAFLD). A new medication is to be taken orally 3 times …
CONDITION: Inflammatory and Immune System
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Active, not recruiting
*** This trial is conducted online *** Psychological distress in people diagnosed with cancer is common and can have a number of negative consequences for affected people, including a reduced …
CONDITION: Mental Health
GENDER: Females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
SLT for Vascular Dementia Vascular dementia (VaD) is the second major cause of dementia accounting for 15-20 per cent of all dementia cases. VaD is an acquired cognitive impairment due …
CONDITION: Neurological
GENDER: Both males and females
AGE GROUP: 40 and above
TRIAL STATUS: Active, not recruiting
Project Title: Role of Sympathetic Activation in Ischemia Reperfusion Injury The aim of the study is to investigate the effectiveness of remote ischemic preconditioning (RIPC) in healthy male individuals. …
CONDITION: Cardiovascular
GENDER: Males
AGE GROUP: 60 to 75 years
TRIAL STATUS: Recruiting
Project Title: Multi-Organ Denervation to Reduce Sympathetic Drive The purpose of this research study is to evaluate the safety of liver denervation, kidney denervation and a combination of both …
CONDITION: Cardiovascular
GENDER: Both males and females
AGE GROUP: 22 to 70 years
TRIAL STATUS: Recruiting
Project Title: Global Clinical Study of Renal Denervation with the Symplicity SPYRALTM multi-electrode renal denervation system in Patients with Uncontrolled Hypertension on Standard Medical Therapy In some individuals with hypertension, …
CONDITION: Cardiovascular
GENDER: Both males and females
AGE GROUP: 20 to 80 years
TRIAL STATUS: Recruiting
An Australian researcher is testing an investigational product (Hidracare). In this study, we are trying to find out if Hidracare solution, a salt mixture, could improve the skin condition Hidradentitis …
CONDITION: Skin
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Completed
Project Title: The Role of Neuroinflammation in Hypertension – Minocycline for Resitant for Hypertension: A Randomised, double-blind, placebo-controlled trial The objective of this study is to establish whether or …
CONDITION: Cardiovascular
GENDER: Both males and females
AGE GROUP: 45 to 65 years
TRIAL STATUS: Recruiting
Project Title: Effects of SGLT-2 inhibition on Sympathetic Nervous System Activity in Humans This research study aims to assess whether Jardiance® (otherwise known as Empagliflozin), a medication approved for …
CONDITION: Cardiovascular
GENDER: Both males and females
AGE GROUP: 25 to 65 years
TRIAL STATUS: Recruiting
Project Title: Sympathoinhibition as a preferred second line treatment of obesity related hypertension This research study aims to optimise the treatment of hypertension in individuals with obesity. It will compare …
CONDITION: Cardiovascular
GENDER: Both males and females
AGE GROUP: 25 to 70 years
TRIAL STATUS: Recruiting
CONDITION: Other
GENDER: Both males and females
AGE GROUP: 18 to 65 years
TRIAL STATUS: Recruiting
OVERVIEW The Holdsworth House Research team are currently looking for study participants who suffer from dust-related fibrotic respiratory diseases, such as coal workers pneumoconiosis (CWP, or Black Lung), silicosis, diffuse …
CONDITION: Respiratory
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
OVERVIEW The Holdsworth House Research team are currently looking for study participants who suffer from Urinary Tract Infections (UTIs). We are investigating a new potential treatment for acute cystitis. The …
CONDITION: Renal and Urogenital
GENDER: Females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
OVERVIEW The Holdsworth House Research team are currently seeking volunteers for early stage research for HIV. There is no cost for study medication, and travel costs can be reimbursed. To …
CONDITION: Inflammatory and Immune System
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
Do you think you have Gonorrhoea? Gonorrhoea can cause serious health problems. A clinical research study for gonorrhoea may be an option for you. You may qualify for this no-cost …
CONDITION:
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
OVERVIEW The Holdsworth House Research team are currently looking for study participants who suffer from Migraines. The investigational product may reduce number of headache days. There is no cost for …
CONDITION: Neurological
GENDER: Both males and females
AGE GROUP: 18 to 70 years
TRIAL STATUS: Recruiting
Have you been vaccinated against Meningococcal Disease? The Holdsworth House Research team are currently recruiting for a study using investigational vaccines against Meningococcal Disease. If you are aged 18-25, have …
CONDITION: Infection
GENDER: Both males and females
AGE GROUP: 18 to 25 years
TRIAL STATUS: Recruiting
OVERVIEW The Holdsworth House Research team are currently seeking volunteers to trial a new possible Type 2 Diabetes therapy. We are seeking patients whose diabetes control could be improved. There …
CONDITION: Metabolic and Endocrine
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
Researchers at NICM Health Research Institute are seeking participants to join a clinical trial investigating the effectiveness and safety of an herbal medicine for the management of osteoarthritis of the …
CONDITION: Musculoskeletal
GENDER: Both males and females
AGE GROUP: 40 to 75 years
TRIAL STATUS: Closed: follow-up complete
Research Centre: NICM Health Research Institute, Western Sydney University Location: Online and via phone. No face to face contact is required with any member of the research team. Lead Doctor: …
CONDITION: Other
GENDER: Both males and females
AGE GROUP: 18 to 65 years
TRIAL STATUS: Completed
Primary Objective: To determine the change in the following parameters following administration of RadianiX ™ Skin Melanin Index and Erythema Score Skin Hyperpigmentation Skin Elasticity Visual Skin Properties Skin Luminosity …
CONDITION: Skin
GENDER: Females
AGE GROUP: 30 to 65 years
TRIAL STATUS: Completed
CheckMate-901 is a phase 3 open-label clinical research study of drugs named nivolumab and ipilimumab. This study will test these drugs in adults with cancer of the bladder or upper …
CONDITION: Cancer
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Completed
This is an open-label Phase 1/2 study to assess the safety and tolerability of combination PD-1 inhibitor (nivolumab) administered concomitantly with c-Met inhibitor (APL-101), to determine the recommended Phase 2 …
CONDITION: Cancer
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Terminated
POLARIS is a Phase 2 research trial testing a potential new treatment for BRAFV600-mutant positive melanoma that has spread to the brain. The new treatment is called encorafenib (Braftovi) + …
CONDITION: Cancer
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Terminated
This is a Phase III, randomized, double-blind, placebo-controlled, multi-center, global study to assess the efficacy and safety of durvalumab in combination with bevacizumab or durvalumab monotherapy or placebo as adjuvant …
CONDITION: Cancer
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Closed: follow-up continuing